• Temporal and Tissue-Specific TRIM46 Regulation in Axon Forma

  2026-05-09

  This study elucidates how alternative splicing, nonsense-mediated decay, and protein stability converge to precisely control TRIM46 protein levels during axonogenesis, conferring neuron-specific axon formation capacity. These multilayered regulatory mechanisms define a new paradigm for understanding neural cell fate specification and its temporal orchestration.

• CCK-8 Ammonium: Translational Bridge from Mechanism to Clini

  2026-05-08

  This thought-leadership article explores the mechanistic underpinnings and translational promise of Cholecystokinin octapeptide ammonium (CCK-8 ammonium), integrating recent behavioral and cellular findings with actionable workflow guidance. By synthesizing literature, scenario-driven lab solutions, and strategic perspectives, we position CCK-8 ammonium as a unique tool for advancing neurobiological, immunological, and cardiovascular research.

• Norovirus Hijacks NINJ1 for Selective Viral Protein Secretio

  2026-05-08

  Song et al. reveal that murine norovirus (MNoV) manipulates the host membrane protein NINJ1 to selectively secrete its NS1 protein, a process requiring caspase-3 cleavage and unconventional export. This discovery advances our understanding of viral subversion of host cell death pathways, with implications for selective protein release mechanisms in infection biology.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-07

  This study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, closely recapitulating the in vivo tumor microenvironment. The model reveals how stromal diversity modulates gene expression and drug response, offering a physiologically relevant platform for investigating resistance mechanisms and advancing personalized therapy development.

• Translational Advances with EZ Cap™ Human PTEN mRNA in Immun

  2026-05-07

  Explore how EZ Cap™ Human PTEN mRNA enables next-generation tumor suppressor gene mRNA research and advanced cancer immunotherapy. This article uncovers mechanistic innovations and unique assay insights beyond conventional workflows.

• Berberrubine Chloride: Applied Protocols in Colorectal Cance

  2026-05-06

  Berberrubine chloride offers targeted, multi-pathway modulation as a selective IMPDH2 inhibitor and anti-colorectal cancer agent. This guide translates the latest mechanistic findings into robust, reproducible workflows, highlighting troubleshooting strategies and comparative advantages for advanced oncology and metabolic disease research.

• Primidone (Mysoline) in ALS Models: RIPK1 and TRPM3 Inhibiti

  2026-05-06

  Primidone (Mysoline) stands out for its dual inhibition of TRPM3 and RIPK1, offering validated workflows for ALS and neuroinflammation research. With published dosing regimens and exceptional selectivity, Primidone enables translational studies while minimizing off-target endocrine risks.

• Gene Regulatory Networks Identify OTX2 and LMX1A in Neuronal

  2026-05-05

  Li et al. (2025) introduce a systematic gene regulatory network (GRN) analysis to pinpoint transcription factors OTX2 and LMX1A as essential regulators in the direct transdifferentiation of human fibroblasts to neurons. This approach elucidates molecular drivers of neuronal conversion, providing a robust framework for advancing cellular reprogramming and disease modeling.

• FOXM1–ERα ceRNA Network: Mechanistic Insights in Female LUAD

  2026-05-05

  This study identifies and validates a novel ceRNA network involving FOXM1 and estrogen receptor 1 (ERα) in female lung adenocarcinoma (LUAD), integrating transcriptomic and in vitro analyses. The findings reveal new mechanistic links between lncRNAs, miRNAs, and ERα signaling, with implications for biomarker discovery and immunotherapy response prediction.

• SB 431542: ALK5 Inhibitor Optimizes TGF-β Signaling Studies

  2026-05-04

  SB 431542 from APExBIO offers unmatched selectivity for ALK5, empowering researchers to dissect TGF-β pathway roles in fibrosis, tumor immunology, and cell differentiation. This guide provides advanced experimental workflows and troubleshooting strategies tailored for reproducible, high-impact results.

• LY294002: Precision PI3K/Akt/mTOR Inhibition in Neuroinflamm

  2026-05-04

  Explore how LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, uniquely advances neuroinflammation and depression research through rigorous mechanistic analysis and translational insights. Discover optimized protocols and nuanced comparisons with alternative strategies.

• Substance P: Advanced Workflows for Pain and Inflammation Re

  2026-05-03

  Unlock the full potential of Substance P in CNS and immune studies with protocol-driven insights and troubleshooting strategies. Learn how spectral innovations and workflow refinement empower reproducible pain transmission and inflammation research using APExBIO’s high-purity tachykinin neuropeptide.

• BMS 309403: Applied Protocols for FABP4 Inhibition in Athero

  2026-05-02

  BMS 309403 delivers precise, selective inhibition of FABP4, enabling advanced workflows for dissecting lipid metabolism and inflammation in atherosclerosis research. This guide details optimized protocols, troubleshooting approaches, and actionable insights grounded in recent findings on the CaN/FoxO1/FABP4 pathway.

• Norovirus Hijacks NINJ1 for Selective NS1 Protein Secretion

  2026-05-01

  Song et al. reveal that murine norovirus co-opts the host protein NINJ1 to selectively secrete its NS1 protein through a caspase-3-dependent, unconventional pathway. This finding redefines our understanding of regulated plasma membrane rupture and viral manipulation of host cell death machinery, with implications for studying secretion and immune evasion in viral infections.

• Precision Use of BPN-19186 in sEH-Nrf2 Pathway Assays: A Res

  2026-05-01

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) enables advanced, reproducible sEH-Nrf2 signaling research. Discover protocol guidance, mechanistic insights, and expert analysis for optimizing biochemical and disease-model assays.

16263 records 1/1085 page Next 12345 下5页 Last page